Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent updates on drug resistance in Mycobacterium tuberculosis
R. K. Brojen Singh, Shri Prakash Dwivedi, Usha Singh Gaharwar, et al.
Journal of Applied Microbiology (2019) Vol. 128, Iss. 6, pp. 1547-1567
Open Access | Times Cited: 274

Showing 1-25 of 274 citing articles:

Novel approaches for vaccine development
Makda S. Gebre, Luis A. Brito, Lisa H. Tostanoski, et al.
Cell (2021) Vol. 184, Iss. 6, pp. 1589-1603
Open Access | Times Cited: 244
Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment
Anna Allué‐Guardia, Juan Ignacio García, Jordi B. Torrelles
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 168
Drug resistant Tuberculosis: A review
Jessy Lallungawi Khawbung, Durbba Nath, Supriyo Chakraborty
Comparative Immunology Microbiology and Infectious Diseases (2020) Vol. 74, pp. 101574-101574
Closed Access | Times Cited: 164
Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19
Karla Therese L. Sy, Nel Jason Haw, Jhanna Uy
Infectious Diseases (2020) Vol. 52, Iss. 12, pp. 902-907
Open Access | Times Cited: 154
Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance
Radha Gopalaswamy, Azger Dusthackeer, Silambuchelvi Kannayan, et al.
Journal of Respiration (2021) Vol. 1, Iss. 2, pp. 141-164
Open Access | Times Cited: 98
Drug-Resistant Tuberculosis 2020: Where We Stand
Angelo Iacobino, Lanfranco Fattorini, Federico Giannoni
Applied Sciences (2020) Vol. 10, Iss. 6, pp. 2153-2153
Open Access | Times Cited: 76
Machine learning analysis of SERS fingerprinting for the rapid determination of Mycobacterium tuberculosis infection and drug resistance
Liang Wang, Xue-Di Zhang, Jia-Wei Tang, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 5364-5377
Open Access | Times Cited: 45
Tuberculosis of the spine
Wattana Leowattana, Pathomthep Leowattana, Tawithep Leowattana
World Journal of Orthopedics (2023) Vol. 14, Iss. 5, pp. 275-293
Open Access | Times Cited: 33
Niosome as an Effective Nanoscale Solution for the Treatment of Microbial Infections
Mahmood Barani, Fatemeh Paknia, Maryam Roostaee, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 25
Actionable mechanisms of drug tolerance and resistance in Mycobacterium tuberculosis
Dipanwita Datta, Shaina Jamwal, Nishant Jyoti, et al.
FEBS Journal (2024) Vol. 291, Iss. 20, pp. 4433-4452
Open Access | Times Cited: 13
Unraveling Dilemmas and Lacunae in the Escalating Drug Resistance of Mycobacterium tuberculosis to Bedaquiline, Delamanid, and Pretomanid
Anjali Negi, Summaya Perveen, Ria Gupta, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2264-2286
Closed Access | Times Cited: 12
Roles of HIF-1α signaling in Mycobacterium tuberculosis infection: New targets for anti-TB therapeutics?
Chaowei Li, Jiajun Wang, Jun‐Fa Xu, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 711, pp. 149920-149920
Closed Access | Times Cited: 9
Identification of bioactive natural compounds as efficient inhibitors against Mycobacterium tuberculosis protein-targets: A molecular docking and molecular dynamics simulation study
Sravan Kumar Miryala, Soumya Basu, Aniket Naha, et al.
Journal of Molecular Liquids (2021) Vol. 341, pp. 117340-117340
Closed Access | Times Cited: 43
Exploring the applications of hyaluronic acid‐based nanoparticles for diagnosis and treatment of bacterial infections
Mahir M. Sharif, Nikita Devnarain, Eman Elhassan, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 36
Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation
Shasank S. Swain, Sanghamitra Pati, Tahziba Hussain
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114173-114173
Closed Access | Times Cited: 34
Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
Kona Chowdhury, Rahnuma Ahmad, Susmita Sinha, et al.
Cureus (2023)
Open Access | Times Cited: 23
Innovative Therapeutic Approaches Based on Nanotechnology for the Treatment and Management of Tuberculosis
Pooneh Kia, Umme Ruman, Ariyati Retno Pratiwi, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1159-1191
Open Access | Times Cited: 21
Drug Resistance: An Incessant Fight against Evolutionary Strategies of Survival
Francisco Ramos‐Martín, Nicola D’Amelio
Microbiology Research (2023) Vol. 14, Iss. 2, pp. 507-542
Open Access | Times Cited: 17
Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus
Li Zhao, Ke Fan, Xue‐Zhi Sun, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
Biogenic Zinc Oxide Nanoparticles: An Insight into the Advancements in Antimicrobial Resistance
Avinash Sharma, K. Akash, Swati Kumari, et al.
ECS Journal of Solid State Science and Technology (2024) Vol. 13, Iss. 4, pp. 047002-047002
Closed Access | Times Cited: 8
Metabolic Rewiring of Mycobacterium tuberculosis upon Drug Treatment and Antibiotics Resistance
Biplab Singha, Sumit Murmu, Tripti Nair, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 63-63
Open Access | Times Cited: 7
Unlocking InhA: Novel approaches to inhibit Mycobacterium tuberculosis
Simranpreet K. Wahan, Gaurav Bhargava, Viney Chawla, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107250-107250
Closed Access | Times Cited: 7
Status and challenges for tuberculosis control in India – Stakeholders' perspective
Gargi Thakur, Shalvi Thakur, Harshad Thakur
Indian Journal of Tuberculosis (2020) Vol. 68, Iss. 3, pp. 334-339
Open Access | Times Cited: 50
The ATP-Binding Cassette (ABC) Transport Systems in Mycobacterium tuberculosis: Structure, Function, and Possible Targets for Therapeutics
Marcelo Cassio Barreto de Oliveira, Andrea Balan
Biology (2020) Vol. 9, Iss. 12, pp. 443-443
Open Access | Times Cited: 44
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance
Summaya Perveen, Diksha Kumari, Kuljit Singh, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114066-114066
Closed Access | Times Cited: 40
Page 1 - Next Page

Scroll to top